REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $418 | -99.9% | 11 | -100.0% | 0.00% | -100.0% |
| Q3 2022 | $767,000 | -73.9% | 30,518 | -68.4% | 0.00% | -80.0% |
| Q2 2022 | $2,935,000 | +881.6% | 96,598 | +959.5% | 0.01% | +900.0% |
| Q1 2022 | $299,000 | -92.2% | 9,117 | -93.7% | 0.00% | -92.3% |
| Q4 2021 | $3,811,000 | -82.7% | 144,521 | -34.6% | 0.01% | -88.0% |
| Q1 2021 | $22,044,000 | +200.6% | 221,109 | +193.7% | 0.11% | +100.0% |
| Q3 2020 | $7,334,000 | +265.8% | 75,284 | +441.8% | 0.05% | +125.0% |
| Q1 2020 | $2,005,000 | – | 13,895 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
| Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
| First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
| Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
| Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
| Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
| MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
| Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
| KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
| EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |